SCHEMBL19458

SCHEMBL19458

CC(C)(C)OC(=O)CN(CCN(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ALOX15 P16050 2/20 0.42
BLM P54132 2/20 0.42
PMP22 Q01453 2/20 0.42
CYP2C19 P33261 2/20 0.42
LMNA P02545 1/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2A P08913 1/20 0.42
TSHR P16473 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
DRD3 P35462 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
EYA2 O00167 1/20 0.39
APP P05067 1/20 0.39
ACE P12821 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7567960 0.92 CHRM2 (0.37) TDP1KDM4EALOX15BLMPMP22
SCHEMBL438113 0.92 TDP1 (0.58) TDP1KDM4EALOX15BLMPMP22
SCHEMBL29484958 0.92 CA14 (0.38) TDP1KDM4EALOX15BLMPMP22
SCHEMBL992084 0.92 TDP1 (0.58) TDP1KDM4EALOX15BLMPMP22
SCHEMBL4621864 0.92 TDP1 (0.58) TDP1KDM4EALOX15BLMPMP22
SCHEMBL13635956 0.90 TDP1 (0.35) TDP1KDM4EALOX15BLMPMP22
SCHEMBL13787056 0.90 TDP1 (0.35) TDP1KDM4EALOX15BLMPMP22
SCHEMBL15178401 0.90 TDP1 (0.35) TDP1KDM4EALOX15BLMPMP22
SCHEMBL24896787 0.90 NR1D1 (0.33) TDP1KDM4EALOX15BLMPMP22
SCHEMBL7564036 0.89 NR1D1 (0.36) TDP1KDM4EALOX15BLMPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9855338-B2 Polyglutamate-amino acid conjugates and methods NITTO DENKO CORPORATION (JP) 2018-01-02 US disclosed
US-20170119889-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS NITTO DENKO CORPORATION (JP) 2017-05-04 US disclosed
US-20170119889-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS NITTO DENKO CORPORATION (JP) 2017-05-04 US disclosed
EP-2155255-B1 Compositions that include a hydrophobic compound and a polyamino acid conjugate NITTO DENKO CORP (JP) 2013-08-14 EP disclosed
US-8329199-B2 Compositions that include a hydrophobic compound and a polyamino acid conjugate NITTO DENKO CORPORATION (JP) 2012-12-11 US disclosed
EP-2125025-B1 MULTI-FUNCTIONAL DRUG CARRIERS NITTO DENKO CORP (JP) 2012-11-14 EP disclosed
US-20120230917-A1 COMPOSITIONS THAT INCLUDE A HYDROPHOBIC COMPOUND AND A POLYAMINO ACID CONJUGATE NITTO DENKO CORPORATION (JP) 2012-09-13 US disclosed
US-20120189554-A1 MULTI-FUNCTIONAL DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2012-07-26 US disclosed
US-20120189554-A1 MULTI-FUNCTIONAL DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2012-07-26 US disclosed
US-8197828-B2 Compositions that include a hydrophobic compound and a polyamino acid conjugate NITTO DENKO CORPORATION (JP) 2012-06-12 US disclosed
US-20080279782-A1 POLYMERS CONJUGATED WITH PLATINUM DRUGS NITTO DENKO CORPORATION (JP) 2008-11-13 US disclosed
US-20080279782-A1 POLYMERS CONJUGATED WITH PLATINUM DRUGS NITTO DENKO CORPORATION (JP) 2008-11-13 US disclosed
WO-2008124735-A2 MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2008-10-16 WO disclosed
US-20080253969-A1 MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2008-10-16 US disclosed
US-20080253969-A1 MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2008-10-16 US disclosed
WO-2008094834-A2 MULTI-FUNCTIONAL DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2008-08-07 WO disclosed
US-20080181852-A1 Multi-functional Drug Carriers NITTO DENKO CORPORATION (JP) 2008-07-31 US disclosed
WO-2007067417-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS NITTO DENKO CORPORATION (JP) 2007-06-14 WO disclosed
US-20070128118-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS NITTO DENKO CORPORATION (JP) 2007-06-07 US disclosed
US-20070128118-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS NITTO DENKO CORPORATION (JP) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080253969-A1 MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS CD44, SGTA, IDUA TDP1 1203/4885KDM4E 2783/4885ALOX15 4502/4885
US-20120230917-A1 COMPOSITIONS THAT INCLUDE A HYDROPHOBIC COMPOUND AND A POLYAMINO ACID CONJUGATE SLC7A1, MSN, CD44 TDP1 2615/4885KDM4E 4480/4885ALOX15 3275/4885
US-20070128118-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS FOLH1, SLC7A1, SLC3A2 TDP1 1214/4885KDM4E 3657/4885ALOX15 4524/4885
US-20080181852-A1 Multi-functional Drug Carriers SLC7A1, SLC19A1, SLC43A1 TDP1 2536/4885KDM4E 3214/4885ALOX15 4052/4885
US-20170119889-A1 POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS FOLH1, SLC7A1, SLC3A2 TDP1 1214/4885KDM4E 3657/4885ALOX15 4524/4885
US-20080279782-A1 POLYMERS CONJUGATED WITH PLATINUM DRUGS FOLR1, PAICS, ABCC1 TDP1 1403/4885KDM4E 4654/4885ALOX15 3815/4885
US-20120189554-A1 MULTI-FUNCTIONAL DRUG CARRIERS SLC7A1, SLC19A1, SLC43A1 TDP1 2536/4885KDM4E 3214/4885ALOX15 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.